经蝶窦手术后低钠血症的管理与结局:一项回顾性观察研究
该研究基于前瞻性维护数据库回顾性分析2016年1月至2019年12月4年间670例经蝶窦手术患者,低钠血症发生率为24.2%(162/670),中位年龄56岁,女性及较年轻与低钠血症相关,术后第7天平均最低血钠128.6 mmol/L;低钠血症患者住院时间更长,血钠≤132 mmol/L者以SIADH最常见(72%),限水单药治疗3天后32.9%未升钠,6.8%因低钠再入院。
要点
- 经蝶窦手术后低钠血症发生率为24.2%(162/670),女性及较年轻患者更易发生。
- 低钠血症患者住院时间更长,最低血钠与住院时长呈负相关(p < 0.001)。
- 血钠≤132 mmol/L者SIADH最常见(80/111;72%),限水单药治疗3天后32.9%未升钠。
核心结论
- 低钠血症在经蝶窦手术后相对常见,与住院时间延长和再入院风险相关,限水治疗的有效性有限,作者认为需进一步研究以更好识别和治疗高危患者,包括使用精氨酸加压素受体拮抗剂。
研究设计与样本
- 回顾性观察研究,检索2016年1月至2019年12月4年间前瞻性维护数据库,纳入所有经蝶窦手术患者,通过回顾病历提取低钠血症管理与结局数据。
主要发现
- 低钠血症发生于162例患者(162/670;24.2%),中位年龄56岁,女性及较年轻与低钠血症相关,术后第7天平均最低血钠为128.6 mmol/L。
- 低钠血症患者住院时间长于血钠正常组,最低血钠与住院时长呈负相关(p < 0.001)。
- 血清钠≤132 mmol/L的患者中,SIADH为最常见原因(80/111;72%)。
- 76例以限水作为单药治疗的患者中,25例(25/76;32.9%)治疗3天后血钠未升高。
- 因低钠血症再入院11例(11/162;6.8%),中位间隔为术后9天。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hyponatraemia is a common complication following transsphenoidal surgery. However, there is sparse data on its optimal management and impact on clinical outcomes. The aim of this study was to evaluate the management and outcome of hyponatraemia following transsphenoidal surgery. METHODS: A prospectively maintained database was searched over a 4-year period between January 2016 and December 2019, to identify all patients undergoing transsphenoidal surgery. A retrospective case-note review was performed to extract data on hyponatraemia management and outcome. RESULTS: Hyponatraemia occurred in 162 patients (162/670; 24.2%) with a median age of 56 years. Female gender and younger age were associated with hyponatraemia, with mean nadir sodium being 128.6 mmol/L on postoperative day 7. Hyponatraemic patients had longer hospital stay than normonatraemic group with nadir sodium being inversely associated with length of stay (p < 0.001). In patients with serum sodium ≤ 132 mmol/L, syndrome of inappropriate antidiuretic hormone secretion (SIADH) was the commonest cause (80/111; 72%). Among 76 patients treated with fluid restriction as a monotherapy, 25 patients (25/76; 32.9%) did not achieve a rise in sodium after 3 days of treatment. Readmission with hyponatraemia occurred in 11 cases (11/162; 6.8%) at a median interval of 9 days after operation. CONCLUSION: Hyponatraemia is a relatively common occurrence following transsphenoidal surgery, is associated with longer hospital stay and risk of readmission and the effectiveness of fluid restriction is limited. These findings highlight the need for further studies to better identify and treat high-risk patients, including the use of arginine vasopressin receptor antagonists.
引用
- Hussein Z, Tzoulis P, Marcus HJ, et al. The management and outcome of hyponatraemia following transsphenoidal surgery: a retrospective observational study. Acta Neurochir (Wien). 2022. PMID: 35079890. doi:10.1007/s00701-022-05134-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。